Key Record Dates
ClinicalTrials.gov Identifier: | NCT04463004 |
---|---|
Brief Title: | Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation |
First Submitted : | July 7, 2020 |
First Submitted that Met QC Criteria : | July 7, 2020 |
First Posted : | July 9, 2020 |
Last Update Submitted that Met QC Criteria : | February 16, 2021 |
Last Update Posted : | February 17, 2021 |